Equities research analysts expect Grupo Aeroportuario del Centro Nort (NASDAQ:OMAB) to report earnings of $0.73 per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Grupo Aeroportuario del Centro Nort’s earnings. Grupo Aeroportuario del Centro Nort reported earnings per share of $0.74 during the same quarter last year, which would suggest a negative year-over-year growth rate of 1.4%. The company is scheduled to report its next earnings results on Wednesday, July 17th. According... 

Brokerages forecast that Amarin Co. plc (NASDAQ:AMRN) will report ($0.03) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Four analysts have issued estimates for Amarin’s earnings, with the highest EPS estimate coming in at ($0.02) and the lowest estimate coming in at ($0.03). Amarin reported earnings per share of ($0.10) during the same quarter last year, which would indicate a positive year-over-year growth rate of 70%. The company is expected to issue its next quarterly earnings report on Wednesday,... 

Shares of Hilton Hotels Co. (NYSE:HLT) have been given a consensus recommendation of “Buy” by the nineteen analysts that are currently covering the company, Marketbeat.com reports. Five analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $89.96. A number of analysts have issued reports on HLT shares. Citigroup raised their target price on Hilton Hotels from $84.00... 

Shares of PPL Corp (NYSE:PPL) have earned an average recommendation of “Hold” from the fifteen ratings firms that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating on the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $34.00. Several research firms recently weighed in on PPL. Zacks Investment Research downgraded PPL... 

Shares of Daily Mail and General Trust P L C (LON:DMGT) have been assigned a consensus rating of “Hold” from the nine ratings firms that are covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a sell recommendation, three have given a hold recommendation and three have issued a buy recommendation on the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is GBX 685.57 ($8.96). DMGT has been the topic of a number of research reports. Goldman... 

DiamondRock Hospitality (NYSE:DRH) declared a quarterly dividend on Monday, June 17th, Wall Street Journal reports. Stockholders of record on Friday, June 28th will be given a dividend of 0.125 per share by the real estate investment trust on Friday, July 12th. This represents a $0.50 annualized dividend and a dividend yield of 5.00%. The ex-dividend date is Thursday, June 27th. DiamondRock Hospitality has increased its dividend payment by an average of 1.5% per year over the last three years. DiamondRock Hospitality has a payout ratio of 49.5%... 

First Capital Realty Inc (TSE:FCR) declared a quarterly dividend on Thursday, June 27th, TickerTech reports. Stockholders of record on Thursday, July 18th will be paid a dividend of 0.215 per share on Thursday, July 18th. This represents a $0.86 dividend on an annualized basis and a dividend yield of 3.86%. The ex-dividend date of this dividend is Thursday, June 27th. Shares of FCR opened at C$22.30 on Wednesday. First Capital Realty has a 1 year low of C$18.28 and a 1 year high of C$22.49. The company has a quick ratio of 0.08, a current ratio... 

BidaskClub lowered shares of Cogent Communications (NASDAQ:CCOI) from a hold rating to a sell rating in a report issued on Saturday morning, BidAskClub reports. A number of other analysts also recently issued reports on CCOI. Royal Bank of Canada lifted their target price on Cogent Communications from $48.00 to $50.00 and gave the company a sector perform rating in a research report on Monday, February 25th. ValuEngine raised Cogent Communications from a hold rating to a buy rating in a research report on Thursday, March 14th. Zacks Investment Research... 

ValuEngine lowered shares of ICF International (NASDAQ:ICFI) from a buy rating to a hold rating in a research report report published on Saturday morning, ValuEngine reports. Several other equities research analysts also recently weighed in on the stock. Barrington Research reissued an outperform rating and issued a $88.00 target price (up previously from $86.00) on shares of ICF International in a research note on Thursday, May 9th. Cowen reissued a buy rating and issued a $82.00 target price on shares of ICF International in a research note... 

Zacks Investment Research reiterated their hold rating on shares of Zebra Technologies (NASDAQ:ZBRA) in a research report released on Saturday morning, Zacks.com reports. The firm currently has a $225.00 price objective on the industrial products company’s stock. According to Zacks, “Zebra builds tracking technology and solutions that generate actionable information and insight, giving companies unprecedented visibility into their businesses by giving physical things a digital voice. Zebra’s extensive portfolio of solutions give... 

Zacks Investment Research upgraded shares of Encore Wire (NASDAQ:WIRE) from a sell rating to a hold rating in a research report sent to investors on Saturday, Zacks.com reports. According to Zacks, “Encore Wire Corporation is a low-cost manufacturer of copper electrical building wire and cable. The Company is a significant supplier of both residential wire for interior electrical wiring in homes, apartments and manufactured housing, as well as building wire for electrical distribution in commercial and industrial buildings. “ WIRE... 

ValuEngine upgraded shares of Servicesource International (NASDAQ:SREV) from a sell rating to a hold rating in a research note released on Sunday morning, ValuEngine reports. SREV opened at $0.97 on Friday. The company has a quick ratio of 2.26, a current ratio of 2.26 and a debt-to-equity ratio of 0.32. Servicesource International has a 1-year low of $0.85 and a 1-year high of $4.06. The company has a market capitalization of $92.38 million, a P/E ratio of -24.25 and a beta of 1.71. The stock has a 50 day simple moving average of $1.01. Servicesource... 

U.S. Energy (NASDAQ:USEG) and SM Energy (NYSE:SM) are both small-cap oils/energy companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, dividends, risk, institutional ownership and valuation. Profitability This table compares U.S. Energy and SM Energy’s net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets U.S. Energy -15.20% -8.04% -5.69% SM Energy 0.82% -1.52% -0.65% Insider & Institutional... 

Yunji (NASDAQ:YJ) and Titan Machinery (NASDAQ:TITN) are both companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, valuation and earnings. Analyst Ratings This is a breakdown of recent recommendations and price targets for Yunji and Titan Machinery, as provided by MarketBeat.com. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Yunji 0 0 2 0 3.00 Titan Machinery 0 1 1 0 2.50 Yunji... 

Cintas (NASDAQ:CTAS) and Kontoor Brands (NYSE:KTB) are both industrial products companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk. Profitability This table compares Cintas and Kontoor Brands’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Cintas 12.44% 25.85% 11.17% Kontoor Brands N/A N/A N/A Valuation & Earnings This... 

Whiting Petroleum (NYSE:WLL) has been assigned a $21.00 price objective by investment analysts at Morgan Stanley in a research report issued to clients and investors on Monday, Stock Target Advisor reports. The brokerage presently has a “hold” rating on the oil and gas exploration company’s stock. Morgan Stanley’s target price would indicate a potential upside of 21.67% from the stock’s current price. WLL has been the subject of several other research reports. Capital One Financial upgraded shares of Whiting Petroleum... 

ValuEngine cut shares of Kite Realty Group Trust (NYSE:KRG) from a hold rating to a sell rating in a research report report published on Saturday, ValuEngine reports. A number of other equities research analysts also recently weighed in on KRG. Raymond James downgraded shares of Kite Realty Group Trust from an outperform rating to a market perform rating in a research note on Tuesday, February 26th. Bank of America downgraded shares of Kite Realty Group Trust from a neutral rating to an underperform rating in a research note on Monday, March 4th.... 

ValuEngine lowered shares of Allegiant Travel (NASDAQ:ALGT) from a hold rating to a sell rating in a research report released on Saturday morning, ValuEngine reports. Other equities analysts also recently issued reports about the stock. BidaskClub raised shares of Allegiant Travel from a hold rating to a buy rating in a report on Tuesday, April 30th. Deutsche Bank set a $160.00 price objective on shares of Allegiant Travel and gave the stock a buy rating in a report on Friday, March 1st. Morgan Stanley cut their price objective on shares of Allegiant... 

Biohaven Pharmaceutical Holding Co Ltd (NYSE:BHVN) – Research analysts at Oppenheimer lifted their Q2 2019 earnings per share estimates for shares of Biohaven Pharmaceutical in a report issued on Wednesday, June 19th. Oppenheimer analyst E. Rajavelu now forecasts that the company will earn ($1.40) per share for the quarter, up from their previous estimate of ($1.62). Oppenheimer currently has a “Buy” rating and a $68.00 target price on the stock. Oppenheimer also issued estimates for Biohaven Pharmaceutical’s Q3 2019... 

Spark Therapeutics Inc (NASDAQ:ONCE) – Stock analysts at SunTrust Banks issued their Q2 2019 earnings estimates for Spark Therapeutics in a report issued on Wednesday, June 19th. SunTrust Banks analyst J. Lee anticipates that the biotechnology company will post earnings per share of ($1.28) for the quarter. SunTrust Banks also issued estimates for Spark Therapeutics’ Q3 2019 earnings at ($1.17) EPS, Q4 2019 earnings at ($1.13) EPS, FY2019 earnings at ($4.29) EPS, FY2020 earnings at ($4.22) EPS, FY2021 earnings at ($3.80) EPS, FY2022... 

Equities Research Analysts’ downgrades for Tuesday, June 25th: Danone (OTCMKTS:DANOY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Danone SA is engaged in food processing activities primarily in France and internationally. The Company operates in four business lines: Fresh Dairy Products, Waters, Baby Nutrition, and Medical Nutrition. The Fresh Dairy Products division produces and markets yogurts, fermented fresh dairy products, and other specialized fresh dairy products... 

Brokerages predict that Ferro Co. (NYSE:FOE) will report sales of $425.53 million for the current fiscal quarter, according to Zacks. Three analysts have made estimates for Ferro’s earnings. The highest sales estimate is $437.14 million and the lowest is $413.34 million. Ferro posted sales of $416.24 million in the same quarter last year, which suggests a positive year-over-year growth rate of 2.2%. The company is scheduled to report its next earnings results on Wednesday, July 24th. On average, analysts expect that Ferro will report full-year... 

Wall Street analysts expect JMP Group LLC (NYSE:JMP) to announce $39.88 million in sales for the current fiscal quarter, Zacks reports. Two analysts have made estimates for JMP Group’s earnings, with estimates ranging from $37.70 million to $42.05 million. JMP Group posted sales of $44.26 million in the same quarter last year, which suggests a negative year-over-year growth rate of 9.9%. The firm is expected to report its next quarterly earnings report on Wednesday, July 24th. On average, analysts expect that JMP Group will report full year... 

Brokerages expect Achieve Life Sciences Inc (NASDAQ:ACHV) to announce earnings of ($0.33) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Achieve Life Sciences’ earnings. Achieve Life Sciences reported earnings of ($1.82) per share in the same quarter last year, which would indicate a positive year over year growth rate of 81.9%. The business is scheduled to issue its next quarterly earnings report on Wednesday, August 14th. On average, analysts expect that Achieve Life... 

Research Analysts’ upgrades for Tuesday, June 25th: Aileron Therapeutics (NASDAQ:ALRN) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $1.00 price target on the stock. According to Zacks, “Aileron Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in developing and commercializing a novel class of therapeutics primarily in the United States. The companys lead product includes ALRN-6924, targets the tumor suppressor protein p53 for the treatment... 

Shares of BP Midstream Partners LP (NYSE:BPMP) have been assigned an average rating of “Hold” from the twelve analysts that are currently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a sell recommendation, three have given a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $20.88. Several research firms recently issued reports on BPMP. Zacks Investment... 

Analysts expect Eagle Bancorp Montana Inc (NASDAQ:EBMT) to post earnings of $0.40 per share for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Eagle Bancorp Montana’s earnings, with the highest EPS estimate coming in at $0.41 and the lowest estimate coming in at $0.39. Eagle Bancorp Montana posted earnings of $0.26 per share during the same quarter last year, which suggests a positive year-over-year growth rate of 53.8%. The business is expected to report its next quarterly earnings report on Tuesday, July... 

Robert Half International Inc. (NYSE:RHI) has been given an average rating of “Hold” by the twelve ratings firms that are covering the company, Marketbeat reports. Three analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and three have issued a buy recommendation on the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $68.38. A number of equities analysts have issued reports on RHI shares. Zacks Investment Research... 

Shares of Saga PLC (LON:SAGA) have earned a consensus recommendation of “Hold” from the six brokerages that are presently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is GBX 83.50 ($1.09). SAGA has been the subject of several research analyst reports. JPMorgan Chase & Co. reissued an “underweight” rating... 

Equities research analysts expect Standard Motor Products, Inc. (NYSE:SMP) to report earnings per share of $0.82 for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Standard Motor Products’ earnings. The highest EPS estimate is $0.84 and the lowest is $0.80. Standard Motor Products reported earnings of $0.74 per share during the same quarter last year, which indicates a positive year over year growth rate of 10.8%. The business is scheduled to issue its next earnings report on Thursday,... 

BIOFRONTERA AG/ADR (NASDAQ:BFRA) has received an average broker rating score of 1.00 (Strong Buy) from the one analysts that cover the company, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy rating. Brokerages have set a 1 year consensus target price of $21.75 for the company, according to Zacks. Zacks has also given BIOFRONTERA AG/ADR an industry rank of 74 out of 256 based on the ratings given to its competitors. Several research analysts have weighed in on BFRA shares. Lake Street Capital upped... 

Avantor (NYSE:AVTR) and Accelerate Diagnostics (NASDAQ:AXDX) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, analyst recommendations, dividends, profitability and risk. Analyst Recommendations This is a breakdown of recent recommendations and price targets for Avantor and Accelerate Diagnostics, as provided by MarketBeat. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avantor 0 2 18 0 2.90 Accelerate... 

Bruker (NASDAQ:BRKR) had its price objective raised by Jefferies Financial Group from $45.00 to $56.00 in a report released on Friday, The Fly reports. Jefferies Financial Group currently has a buy rating on the medical research company’s stock. Jefferies Financial Group also issued estimates for Bruker’s Q1 2020 earnings at $0.41 EPS, Q3 2020 earnings at $0.45 EPS, Q4 2020 earnings at $0.56 EPS and FY2020 earnings at $1.84 EPS. Other equities research analysts have also issued reports about the stock. BTIG Research lifted their price... 

BidaskClub upgraded shares of Stemline Therapeutics (NASDAQ:STML) from a hold rating to a buy rating in a research report report published on Saturday, BidAskClub reports. Other equities analysts have also recently issued research reports about the stock. HC Wainwright set a $35.00 price target on shares of Stemline Therapeutics and gave the company a buy rating in a research report on Thursday, June 20th. Roth Capital reaffirmed a buy rating on shares of Stemline Therapeutics in a research report on Thursday, May 23rd. ValuEngine raised shares... 

BidaskClub lowered shares of Republic Bancorp, Inc. KY (NASDAQ:RBCAA) from a hold rating to a sell rating in a research report sent to investors on Friday morning, BidAskClub reports. RBCAA stock opened at $47.39 on Friday. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.17 and a quick ratio of 1.16. The company has a market capitalization of $993.30 million, a P/E ratio of 12.75 and a beta of 0.57. Republic Bancorp, Inc. KY has a 12 month low of $35.17 and a 12 month high of $50.70. The business has a 50 day simple moving average... 

Sprouts Farmers Market (NASDAQ:SFM) had its price target lowered by Wells Fargo & Co from $23.00 to $20.00 in a report released on Friday, The Fly reports. The brokerage currently has a positive rating on the stock. Several other equities research analysts also recently commented on SFM. Bank of America reaffirmed an underperform rating and set a $19.00 price target (down previously from $21.00) on shares of Sprouts Farmers Market in a report on Wednesday, May 29th. BidaskClub downgraded Sprouts Farmers Market from a sell rating to a strong... 

Zacks Investment Research upgraded shares of TheStreet (NASDAQ:TST) from a sell rating to a hold rating in a research note released on Friday morning, Zacks.com reports. According to Zacks, “TheStreet Inc. is a digital financial media company. It is focused on the financial, and mergers and acquisitions environment. The Company’s digital services provides users, subscribers and advertisers content and tools through online, social media, tablet and mobile channels. TheStreet Inc., formerly known as TheStreet Com., is based in New York.... 

Zacks Investment Research reiterated their hold rating on shares of Zafgen (NASDAQ:ZFGN) in a report released on Saturday morning, Zacks.com reports. They currently have a $1.50 target price on the biopharmaceutical company’s stock. According to Zacks, “Zafgen, Inc. is a biopharmaceutical company. The Company develops therapeutics for patients suffering from obesity and obesity-related disorders. Its lead product candidate includes Beloranib, an injection that is in Phase II clinical trials for the treatment of various indications... 

BidaskClub downgraded shares of Core-Mark (NASDAQ:CORE) from a hold rating to a sell rating in a research report sent to investors on Saturday morning, BidAskClub reports. A number of other analysts also recently weighed in on the stock. Zacks Investment Research raised shares of Core-Mark from a hold rating to a buy rating and set a $42.00 target price on the stock in a research report on Tuesday, May 14th. ValuEngine raised shares of Core-Mark from a hold rating to a buy rating in a research report on Friday, May 10th. TheStreet raised shares... 

ValuEngine upgraded shares of North American Palladium (OTCMKTS:PALDF) from a hold rating to a buy rating in a research report report published on Saturday, ValuEngine reports. Separately, BMO Capital Markets initiated coverage on shares of North American Palladium in a report on Thursday, May 16th. They issued an outperform rating on the stock. North American Palladium stock opened at $11.11 on Friday. The business’s 50 day moving average price is $8.91. The company has a quick ratio of 2.09, a current ratio of 2.59 and a debt-to-equity ratio... 

ValuEngine downgraded shares of Investors Real Estate Trust Reit (NYSE:IRET) from a buy rating to a hold rating in a report published on Saturday, ValuEngine reports. A number of other research firms have also issued reports on IRET. Zacks Investment Research lowered Investors Real Estate Trust Reit from a hold rating to a sell rating in a report on Wednesday, May 15th. BMO Capital Markets started coverage on Investors Real Estate Trust Reit in a report on Friday, June 14th. They issued an outperform rating and a $60.25 target price on the stock.... 

Zacks Investment Research upgraded shares of freenet (OTCMKTS:FRTAF) from a sell rating to a hold rating in a research report report published on Friday morning, Zacks.com reports. According to Zacks, “Freenet AG is a mobile communications service provider. The company’s brand portfolio includes the mobilcom-debitel, freenet.de, gravis, media broadcast, klarmobil, freenet digital, freenet energy and motion TM. Freenet AG is headquartered in Budelsdorf, Germany. “ Separately, DZ Bank restated a buy rating on shares of freenet... 

Life Storage Inc (NYSE:LSI) has been given an average recommendation of “Hold” by the nine analysts that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation and seven have assigned a hold recommendation to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $96.00. Several research analysts have recently weighed in on LSI shares. Evercore ISI raised shares of Life Storage from an “underperform”... 

Osmotica Pharmaceuticals PLC (NASDAQ:OSMT) has been given an average broker rating score of 1.25 (Strong Buy) from the four brokers that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a buy recommendation and three have issued a strong buy recommendation on the company. Osmotica Pharmaceuticals’ rating score has improved by 6% in the last 90 days as a result of a number of analysts’ upgrades and downgrades. Brokerages have set a one year consensus price target... 

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) Director Gordon Tunstall sold 1,000 shares of the stock in a transaction on Wednesday, June 19th. The stock was sold at an average price of $51.52, for a total transaction of $51,520.00. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. NASDAQ TRHC opened at $53.43 on Monday. The company has a current ratio of 1.80, a quick ratio of 1.73 and a debt-to-equity ratio of 1.31. The firm has a market capitalization of $1.17 billion, a price-to-earnings ratio... 

Pressure Biosciences (OTCMKTS: PBIO) is one of 25 public companies in the “Analytical instruments” industry, but how does it weigh in compared to its rivals? We will compare Pressure Biosciences to related companies based on the strength of its analyst recommendations, valuation, risk, profitability, earnings, institutional ownership and dividends. Institutional and Insider Ownership 59.2% of shares of all “Analytical instruments” companies are held by institutional investors. 15.9% of Pressure Biosciences shares are held... 

ACI Worldwide (NASDAQ:ACIW) and salesforce.com (NYSE:CRM) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, valuation, dividends and analyst recommendations. Profitability This table compares ACI Worldwide and salesforce.com’s net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets ACI Worldwide 6.20% 8.39% 4.08% salesforce.com 8.26% 8.18% 4.24% Analyst... 

Zacks Investment Research lowered shares of NOVOZYMES A/S/S (OTCMKTS:NVZMY) from a hold rating to a sell rating in a research note issued to investors on Thursday morning, Zacks.com reports. According to Zacks, “Novozymes A/S is primarily engaged in the development, production, and distribution of enzymes. Its business consists of two segments, enzyme business and bio business. The Company’s enzyme business segment offers detergent enzymes that are used in laundry and dishwashing, technical enzymes used in the transformation of starch... 

ValuEngine lowered shares of Humanigen (OTCMKTS:HGEN) from a buy rating to a hold rating in a research report sent to investors on Friday, ValuEngine reports. OTCMKTS HGEN opened at $1.06 on Friday. Humanigen has a 1-year low of $0.27 and a 1-year high of $1.54. About Humanigen Humanigen, Inc, a biopharmaceutical company, engages in developing its proprietary monoclonal antibodies for immunotherapy and oncology treatments. The company's products include lenzilumab and ifabotuzumab, which are monoclonal antibodies derived from Humaneered platform.... 

Zacks Investment Research cut shares of Entertainment One (OTCMKTS:ENTMF) from a hold rating to a sell rating in a research report report published on Thursday, Zacks.com reports. According to Zacks, “Entertainment One Ltd. is engaged in the development, acquisition, production, financing, distribution and sales of entertainment content. The Company provides film, television and music production and sales, family programming, merchandising and licensing and digital content. Entertainment One Ltd. is based in Toronto, Canada. “ Shares...